MRK
Price
$105.65
Change
-$0.62 (-0.58%)
Updated
Dec 6, 6:59 PM EST
56 days until earnings call
NVS
Price
$97.07
Change
+$0.09 (+0.09%)
Updated
Dec 6, 6:59 PM EST
55 days until earnings call
Ad is loading...

MRK vs NVS ᐉ Comparison: Which is Better to Invest?

Header iconMRK vs NVS Comparison
Open Charts MRK vs NVSBanner chart's image
Merck & Co
Price$105.65
Change-$0.62 (-0.58%)
Volume$2.28M
CapitalizationN/A
Novartis AG
Price$97.07
Change+$0.09 (+0.09%)
Volume$2.57M
CapitalizationN/A
View a ticker or compare two or three
MRK vs NVS Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
MRK vs. NVS commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRK is a StrongBuy and NVS is a Buy.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (MRK: $105.63 vs. NVS: $97.05)
Brand notoriety: MRK: Notable vs. NVS: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MRK: 126% vs. NVS: 224%
Market capitalization -- MRK: $253.86B vs. NVS: $200.27B
MRK [@Pharmaceuticals: Major] is valued at $253.86B. NVS’s [@Pharmaceuticals: Major] market capitalization is $200.27B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $561.54B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $79.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRK’s FA Score shows that 3 FA rating(s) are green whileNVS’s FA Score has 3 green FA rating(s).

  • MRK’s FA Score: 3 green, 2 red.
  • NVS’s FA Score: 3 green, 2 red.
According to our system of comparison, NVS is a better buy in the long-term than MRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRK’s TA Score shows that 4 TA indicator(s) are bullish while NVS’s TA Score has 6 bullish TA indicator(s).

  • MRK’s TA Score: 4 bullish, 5 bearish.
  • NVS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NVS is a better buy in the short-term than MRK.

Price Growth

MRK (@Pharmaceuticals: Major) experienced а +4.45% price change this week, while NVS (@Pharmaceuticals: Major) price change was +0.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.96%. For the same industry, the average monthly price growth was +1.98%, and the average quarterly price growth was -8.15%.

Reported Earning Dates

MRK is expected to report earnings on Feb 01, 2024.

NVS is expected to report earnings on Jan 31, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.96% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for MRK with price predictions.
OPEN
A.I.dvisor published
a Summary for NVS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MRK($254B) has a higher market cap than NVS($200B). MRK has higher P/E ratio than NVS: MRK (55.56) vs NVS (25.13). NVS YTD gains are higher at: 18.303 vs. MRK (-2.835). NVS has higher annual earnings (EBITDA): 19.4B vs. MRK (12.3B). NVS has more cash in the bank: 12.7B vs. MRK (8.77B). NVS has less debt than MRK: NVS (25.2B) vs MRK (34.9B). MRK has higher revenues than NVS: MRK (59.3B) vs NVS (54.2B).
MRKNVSMRK / NVS
Capitalization254B200B127%
EBITDA12.3B19.4B63%
Gain YTD-2.83518.303-15%
P/E Ratio55.5625.13221%
Revenue59.3B54.2B109%
Total Cash8.77B12.7B69%
Total Debt34.9B25.2B138%
FUNDAMENTALS RATINGS
MRK vs NVS: Fundamental Ratings
MRK
NVS
OUTLOOK RATING
1..100
1429
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
710
SMR RATING
1..100
6856
PRICE GROWTH RATING
1..100
5548
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
46n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVS's Valuation (9) in the Pharmaceuticals Major industry is in the same range as MRK (14). This means that NVS’s stock grew similarly to MRK’s over the last 12 months.

MRK's Profit vs Risk Rating (7) in the Pharmaceuticals Major industry is in the same range as NVS (10). This means that MRK’s stock grew similarly to NVS’s over the last 12 months.

NVS's SMR Rating (56) in the Pharmaceuticals Major industry is in the same range as MRK (68). This means that NVS’s stock grew similarly to MRK’s over the last 12 months.

NVS's Price Growth Rating (48) in the Pharmaceuticals Major industry is in the same range as MRK (55). This means that NVS’s stock grew similarly to MRK’s over the last 12 months.

NVS's P/E Growth Rating (6) in the Pharmaceuticals Major industry is in the same range as MRK (6). This means that NVS’s stock grew similarly to MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKNVS
RSI
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
52%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
45%
Momentum
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
53%
MACD
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
45%
Bullish Trend 1 day ago
42%
Advances
ODDS (%)
Bullish Trend 3 days ago
48%
Bullish Trend 4 days ago
45%
Declines
ODDS (%)
Bearish Trend 10 days ago
46%
Bearish Trend 10 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
55%
Aroon
ODDS (%)
Bearish Trend 1 day ago
47%
Bullish Trend 1 day ago
36%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARDX5.140.12
+2.49%
Ardelyx
AEP80.361.05
+1.32%
American Electric Power Company
RENB3.360.03
+0.90%
Renovaro Biosciences
LYFT12.21-0.03
-0.25%
Lyft
FGH1.38-0.16
-10.39%
FG Group Holdings

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with NVS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-0.56%
NVS - MRK
50%
Loosely correlated
+0.08%
JNJ - MRK
47%
Loosely correlated
-1.22%
GILD - MRK
43%
Loosely correlated
+0.46%
LLY - MRK
36%
Loosely correlated
+0.19%
ABBV - MRK
34%
Loosely correlated
+1.25%
More

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been loosely correlated with MRK. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NVS jumps, then MRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+0.08%
MRK - NVS
49%
Loosely correlated
-0.56%
GILD - NVS
44%
Loosely correlated
+0.46%
AZN - NVS
43%
Loosely correlated
-0.64%
GSK - NVS
42%
Loosely correlated
-0.44%
SNY - NVS
38%
Loosely correlated
-0.78%
More